Ripo, Neri .
HRN: 04-97-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
CEFTRIAXONE 1G (VIAL)
09/23/2023
09/30/2023
IV
2g
Q24H
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes